Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Clin Med ; 12(6)2023 Mar 16.
Artigo em Inglês | MEDLINE | ID: mdl-36983313

RESUMO

Myopia is the most common ocular disorder worldwide with an increasing prevalence over the past few decades. It is a refractive error associated with excessive growth of the eyeball. Individuals with myopia, especially high myopia, are prone to develop sight-threatening complications. Currently, atropine is the only drug that is used to slow myopia progression in clinical practice. However, there are still areas of uncertainty such as treatment strategy, optimal concentration when considering risk-benefit ratio and active treatment period. Since the prevalence of myopia is much higher in Asian countries, most of the research on myopia control has been conducted in Asia. Data on the efficacy and tolerability to atropine eye drops in the non-Asian population remains limited. In this review, we summarize the results of published clinical trials on the effectiveness and tolerability of atropine eye drops for myopia control in non-Asian regions. The efficacy was evaluated by the mean change in spherical equivalent (SE) or axial length (AL). The tolerability of atropine eye drops was analyzed based on patients complains and adverse events. The results of this review suggest that 0.01% atropine eye drops are effective in non-Asian regions achieving less side effects compared to 0.5% concentration.

2.
Medicina (Kaunas) ; 58(5)2022 May 13.
Artigo em Inglês | MEDLINE | ID: mdl-35630074

RESUMO

Neurotrophic keratitis is a rare degenerative disease of the cornea that can lead to corneal ulceration, scarring, and significant visual impairment. It most commonly occurs in adults and is rarely diagnosed in children. Congenital corneal anesthesia is an extremely rare condition that requires appropriate ophthalmologists' attention in making diagnosis and treatment decisions. This condition usually presents in infancy or early childhood and is characterized by rare blinking rate, decreased tearing or a corneal ulcer that is unresponsive to treatment. In this case report, we describe a patient with multiple systemic and neurological disorders who presented to the ophthalmology department due to corneal erosion unresponsive to treatment. Brain magnetic resonance imaging confirmed bilateral trigeminal hypoplasia and the diagnosis of neurotrophic keratopathy due to bilateral congenital corneal anesthesia was made. The discrepancy between clinical signs and symptoms or treatment non-response in cases of corneal erosions should alert the ophthalmologists to suspect trigeminal dysfunction. MRI is the gold standard to confirm congenital corneal anesthesia and to differentiate from other possible neurotrophic keratitis causes.


Assuntos
Anestesia , Distrofias Hereditárias da Córnea , Úlcera da Córnea , Surdez , Deficiência Intelectual , Ceratite , Doenças Metabólicas , Adulto , Anestesia/efeitos adversos , Criança , Pré-Escolar , Úlcera da Córnea/diagnóstico , Úlcera da Córnea/tratamento farmacológico , Úlcera da Córnea/etiologia , Humanos , Deficiência Intelectual/complicações , Ceratite/complicações , Ceratite/diagnóstico , Ceratite/terapia , Hipotonia Muscular/complicações , Síndrome
3.
Medicina (Kaunas) ; 57(3)2021 Feb 26.
Artigo em Inglês | MEDLINE | ID: mdl-33652663

RESUMO

Leber hereditary optic neuropathy (LHON) is one of the most common inherited mitochondrial optic neuropathies, caused by mitochondrial DNA (mtDNA) mutations. Three most common mutations, namely m.11778G>A, m.14484T>G and m.3460G>A, account for the majority of LHON cases. These mutations lead to mitochondrial respiratory chain complex I damage. Typically, LHON presents at the 15-35 years of age with male predominance. LHON is associated with severe, subacute, painless bilateral vision loss and account for one of the most common causes of legal blindness in young individuals. Spontaneous visual acuity recovery is rare and has been reported in patients harbouring m.14484T>C mutation. Up to date LHON treatment is limited. Idebenone has been approved by European Medicines Agency (EMA) to treat LHON. However better understanding of disease mechanisms and ongoing treatment trials are promising and brings hope for patients. In this article we report on a patient diagnosed with LHON harbouring rare m.11253T>C mutation in MT-ND4 gene, who experienced spontaneous visual recovery. In addition, we summarise clinical presentation, diagnostic features, and treatment.


Assuntos
Atrofia Óptica Hereditária de Leber , DNA Mitocondrial/genética , Humanos , Masculino , Mitocôndrias , Mutação , Atrofia Óptica Hereditária de Leber/diagnóstico , Atrofia Óptica Hereditária de Leber/tratamento farmacológico , Atrofia Óptica Hereditária de Leber/genética , Mutação Puntual
4.
Biomed Tech (Berl) ; 61(6): 579-586, 2016 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-26656606

RESUMO

Visually evoked potentials (VEPs) are signals evoked by a visual stimulus. They consist of brief discrete deflections embedded in background electroencephalographic (EEG) activity, which often has larger amplitude. Background EEG cancelation is a major part of VEPs analysis algorithms often realized by coherent averaging or other methods requiring large minimal amount of registered sweeps. In some cases, especially for pediatric patients, or in poor patient compliance cases, long procedure duration and fatigue might cause impaired attention and non-steady target fixation, affecting the quality of recorded VEPs. The possibility to reconstruct VEPs in every single sweep from limited size ensembles opens new diagnostic possibilities and shortens the registration procedure improving its quality. A proposed method is based on truncated expansion (Karhunen-Loève transform) of VEP signals applying generalized universal basis functions (eigenvectors of covariation matrix) calculated from learning set of sweeps, i.e. an ensemble of collected typical recordings. It realizes the possibility to reconstruct a signal from every single sweep even in limited size ensembles of registered sweeps. Application of adaptively time-shifted basis functions enables optimal reconstruction of the signal with latency shift or jitter.


Assuntos
Potenciais Evocados Visuais , Reconhecimento Visual de Modelos , Algoritmos , Humanos , Estimulação Luminosa
5.
Medicina (Kaunas) ; 48(9): 485-95, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-23168924

RESUMO

The inherited macular dystrophies are characterized by different grade central visual loss and different character macula atrophy, because of retinal pigment epithelium lesion. The cause of photoreceptors degeneration is still not known. In this article, we review subjective and objective ophthalmological examines essential to diagnosis and differential diagnosis of inherited autosomal dominant and autosomal recessive macular dystrophies. It is known seven gene mutations (ABCA4, ELOVL4, PROML1, VMD2, Peripherin/RDS, TIMP3, XLRS), which may cause inherited macular dystrophies development. Inheritance type of inherited macular dystrophies, prevalence, beginning of disease, spread of the disease between female and male, clinic, electroretinography, electrooculography, differential diagnosis, genetic research and prognosis are also reviewed.


Assuntos
Técnicas de Diagnóstico Oftalmológico , Oftalmopatias Hereditárias/diagnóstico , Degeneração Macular/diagnóstico , Antígeno AC133 , Transportadores de Cassetes de Ligação de ATP/genética , Antígenos CD/genética , Bestrofinas , Canais de Cloreto/genética , Diagnóstico Diferencial , Oftalmopatias Hereditárias/classificação , Proteínas do Olho/genética , Feminino , Glicoproteínas/genética , Humanos , Proteínas de Filamentos Intermediários/genética , Degeneração Macular/classificação , Masculino , Glicoproteínas de Membrana/genética , Proteínas de Membrana/genética , Mutação , Proteínas do Tecido Nervoso/genética , Peptídeos/genética , Periferinas , Inibidor Tecidual de Metaloproteinase-3/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...